|
1.
|
Liao X, Siu MK, Au CW, et al: Aberrant
activation of hedgehog signaling pathway in ovarian cancers: effect
on prognosis, cell invasion and differentiation. Carcinogenesis.
30:131–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Chen X, Horiuchi A, Kikuchi N, et al:
Hedgehog signal pathway is activated in ovarian carcinomas,
correlating with cell proliferation: it’s inhibition leads to
growth suppression and apoptosis. Cancer Sci. 98:68–76.
2007.PubMed/NCBI
|
|
3.
|
Ray A, Meng E, Reed E, Shevde LA and
Rocconi RP: Hedgehog signaling pathway regulates the growth of
ovarian cancer spheroid forming cells. Int J Oncol. 39:797–804.
2011.PubMed/NCBI
|
|
4.
|
Mas C and Ruiz i Altaba A: Small molecule
modulation of HH-GLI signaling: current leads, trials and
tribulations. Biochem Pharmacol. 80:712–723. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Stecca B and Ruiz IAA: Context-dependent
regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG
signals. J Mol Cell Biol. 2:84–95. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Zhu H and Lo HW: The human
glioma-associated oncogene homolog 1 (GLI1) family of transcription
factors in gene regulation and diseases. Curr Genomics. 11:238–245.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Mine T, Matsueda S, Gao H, et al: Created
Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors
of taxol-resistant ovarian cancer cells. Oncol Rep. 23:1537–1543.
2010.PubMed/NCBI
|
|
8.
|
Steg AD, Bevis KS, Katre AA, et al: Stem
cell pathways contribute to clinical chemoresistance in ovarian
cancer. Clin Cancer Res. 18:869–881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kudo K, Gavin E, Das S, Amable L, Shevde
LA and Reed E: Inhibition of Gli1 results in altered c-Jun
activation, inhibition of cisplatin-induced upregulation of ERCC1,
XPD and XRCC1 and inhibition of platinum-DNA adduct repair.
Oncogene. 31:4718–4724. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Zhong X, Thornton K and Reed E: Computer
based analyses of the 5′-flanking regions of selected genes
involved in the nucleotide excision repair complex. Int J Oncol.
17:375–380. 2000.
|
|
11.
|
Bonovich M, Olive M, Reed E, O’Connell B
and Vinson C: Adenoviral delivery of A-FOS, an AP-1 dominant
negative, selectively inhibits drug resistance in two human cancer
cell lines. Cancer Gene Ther. 9:62–70. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Li Q, Tsang B, Bostick-Bruton F and Reed
E: Modulation of excision repair cross complementation group 1
(ERCC-1) mRNA expression by pharmacological agents in human ovarian
carcinoma cells. Biochem Pharmacol. 57:347–353. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Reed E: ERCC1 measurements in clinical
oncology. N Engl J Med. 355:1054–1055. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Reed E: DNA damage and repair in
translational oncology: an overview. Clin Cancer Res. 16:4511–4516.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Laner-Plamberger S, Kaser A, Paulischta M,
Hauser-Kronberger C, Eichberger T and Frischauf AM: Cooperation
between GLI and JUN enhances transcription of JUN and selected GLI
target genes. Oncogene. 28:1639–1651. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Li Q, Gardner K, Zhang L, Tsang B,
Bostick-Bruton F and Reed E: Cisplatin induction of ERCC-1 mRNA
expression in A2780/CP70 human ovarian cancer cells. J Biol Chem.
273:23419–23425. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Raivich G: c-Jun expression, activation
and function in neural cell death, inflammation and repair. J
Neurochem. 107:898–906. 2008.PubMed/NCBI
|
|
18.
|
Stecca B and Ruiz i Altaba A: A GLI1-p53
inhibitory loop controls neural stem cell and tumour cell numbers.
EMBO J. 28:663–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Cheng CK, Yeung CM, Hoo RL, Chow BK and
Leung PC: Oct-1 is involved in the transcriptional repression of
the gonadotropin-releasing hormone receptor gene. Endocrinology.
143:4693–4701. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Ruiz i Altaba A: Gli proteins encode
context-dependent positive and negative functions: implications for
development and disease. Development. 126:3205–3216.
1999.PubMed/NCBI
|
|
21.
|
Ruiz i Altaba A: Hedgehog signaling and
the Gli code in stem cells, cancer and metastases. Sci Signal.
4:pt92011.PubMed/NCBI
|
|
22.
|
Carpenter RL and Lo HW: Identification,
functional characterization and pathobiological significance of
GLI1 isoforms in human cancers. Vitam Horm. 88:115–140. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Carpenter RL and Lo HW: Hedgehog pathway
and GLI1 isoforms in human cancer. Discov Med. 13:105–113.
2012.PubMed/NCBI
|
|
24.
|
Lo HW, Zhu H, Cao X, Aldrich A and
Ali-Osman F: A novel splice variant of GLI1 that promotes
glioblastoma cell migration and invasion. Cancer Res. 69:6790–6798.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Agyeman A, Mazumdar T and Houghton JA:
Regulation of DNA damage following termination of Hedgehog (HH)
survival signaling at the level of the GLI genes in human colon
cancer. Oncotarget. 3:854–868. 2012.PubMed/NCBI
|
|
26.
|
Leonard JM, Ye H, Wetmore C and Karnitz
LM: Sonic Hedgehog signaling impairs ionizing radiation-induced
checkpoint activation and induces genomic instability. J Cell Biol.
183:385–391. 2008. View Article : Google Scholar : PubMed/NCBI
|
